Epigenetic reader domain inhibitor dBET57, Purity ≥98%

Cat. No.: X24-05-ZQ442

Epigenetic reader domain inhibitor dBET57, Purity ≥98%

Synonym: 1883863-52-2; dBET 57; dBET-57; Epigenetic reader domain inhibitor

  • CAS Number: 1883863-52-2
  • Compound CID: 118912822
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
dBET57, soluble in DMSO and ethanol and insoluble in water, disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals. It targets BRD4 (BD1).
Molecular Weight
699.18
Molecular Formula
C34H31ClN8O5S
Targets
BRD4 (BD1): 500 nM (DC50)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 89 mg/mL (127.29 mM); Water: Insoluble; Ethanol: 11 mg/mL (15.73 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
dBET57 can be used to investigate targeted protein degradation strategies for BET proteins in cancer research.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.